Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Por um escritor misterioso
Descrição
PDF) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization
WO2014033122A1 - Inhibitors of cd40-traf6 interaction - Google Patents
Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors - ScienceDirect
Development of fluorescent peptide G protein‐coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators - Farmer - 2022 - The FASEB Journal - Wiley Online Library
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. - Abstract - Europe PMC
CXCR2-IN-2, CXCR2 Antagonist
One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect
PDF) CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
de
por adulto (o preço varia de acordo com o tamanho do grupo)